Business
MedMira Increases Market Traction with Approval and Sales for Multiplo Triple Test in Moldova and Ukraine
HALIFAX, Oct. 7 /CNW/ - MedMira Inc., ("MedMira") (TSX Venture: MIR, NASDAQ: MMIRF), a developer ...
About this update from Medmira Inc.
[{"type":"text","content":"\n\n\n\nHALIFAX, Oct. 7 /CNW/ - MedMira Inc., ("MedMira") (TSX Venture: MIR,\nNASDAQ: MMIRF), a developer of rapid diagnostics and rapid flow-through\ntechnology, announced today that it has made an initial shipment of its\nMultiplo HBV/HIV/HCV Rapid Tests (Multiplo HBV/HIV/HCV) to its regional\ndistribution partner in Romania, S.C. Roned International S.R.L. They have\nreceived approval to sell Multiplo HBV/HIV/HCV in Moldova and Ukraine and will\nimmediately begin selling to public health programs and participating in NGO\ntender opportunities.\n\n\n"We are excited to build upon the success we have had with MedMira rapid\ntests in Romania. The Multiplo test is a perfect product for the market here\nin Romania, Moldova, and Ukraine, where HIV/Hepatitis co-infections are on the\nrise," said Dumitru Vescu, Executive Director of S.C. Roned International\nS.R.L. and President of the Romania-Moldova Chamber of Commerce and Industry.\n"We have had a great response with the initial introduction of this product\nand will now move to a wider distribution of these tests to our customers.\nMedMira has been an excellent partner and we look forward to adding new\nMedMira rapid tests to our line of products in the future."\n\n\nMultiplo HBV/HIV/HCV is one of MedMira's multiple rapid diagnostic tests\nwhich simultaneously detect antibodies to HIV and the hepatitis B and C\nviruses in a single drop of blood. Multiplo stands alone as the only\ncommercially available rapid test for HIV and Hepatitis co-infection. Multiplo\nwas launched earlier this year in the United Nations Office on Drugs and Crime\n(UNODC) Behavioural Surveillance Surveys (BSS) Among Injecting Drug Users and\nSex Workers in Romania.\n\n\n"We are seeing exciting growth opportunities in Eastern Europe for\nMedMira's products as governments and healthcare systems continue to integrate\nrapid tests for HIV and Hepatitis in to prevention and control programs," said\nHermes Chan, president and CEO, MedMira Inc. "Dumitru and his team know this\nmarket well and they are continually seeking new opportunities to expand the\ndistribution and sales of our rapid tests in South Eastern Europe."\n\n\nAbout MedMira\n\n\nMedMira is a leading developer and manufacturer of flow-through rapid\ndiagnostics. The company's tests provide hospitals, l...